Table 2 Comparison between neuronal surface antibody group and intracellular antibody group
From: Differences and diversity of autoimmune encephalitis in 77 cases from a single tertiary care center
Characteristics | Neuronal surface antibodies (n = 31) | Intracellular antibodies (n = 25) | P value |
|---|---|---|---|
Baseline | |||
Gender | Â | Â | 0.83 |
 - male | 14 (45.2%) | 12 (48%) |  |
 - female | 17 (54.8%) | 13 (52%) |  |
 median age (years) | 30.5 (2–79) | 45.5 (1–86) | 0.04 |
Presenting symptoms | |||
 Behavior | 14 (45.2%) | 4 (16%) | 0.02 |
 Psychosis/mood | 7 (22.6%) | 3 (12%) | 0.30 |
 Seizures | 12 (38.7%) | 8 (32%) | 0.60 |
 Abnormal movements (total) | 12 (38.7%) | 6 (24%) | 0.24 |
 Generalized dyskinesia/chorea | 5 (16.1%) | 3 (12%) | 0.66 |
CSF profile | |||
 median CSF white blood cell (cells/mm3) | 2 (0–82) | 1 (0–31) | 0.12 |
 median CSF protein (mg/dl) | 26.5 (11–242) | 44 (2–440) | 0.27 |
 median CSF glucose (mg%) | 65.5 (44–149) | 67 (42–95) | 0.46 |
Duration of disease onset to treatment (days) | 15 (1–420) | 20 (1–700) | 0.385 |
Median hospital stay (days) | 23 (4–150) | 31.5 (5–126) | 0.57 |
Outcome at discharge from hospital | |||
 Completely recovered (mRS 0–1) | 3 (9.7%) | 0 (0%) | 0.25 |
 Partially recovered (mRS 2–3) | 20 (64.5%) | 15 (60%) | 0.73 |
 Disable (mRS 4–5) | 7 (22.6%) | 6 (24%) | 0.9 |
 Dead | 1 (3.2%) | 4 (16%) | 0.16 |